
Sign up to save your podcasts
Or


In vivo models have been the drug safety standard for as long as there have been drug safety standards. With mounting data proving the worth of in vitro models, could there be a future where we will not need in vivo? I am joined by Anjli Venkateswaran, Director of Strategic Partnerships for Charles River, to discuss this trending topic.
By Charles River4.7
1414 ratings
In vivo models have been the drug safety standard for as long as there have been drug safety standards. With mounting data proving the worth of in vitro models, could there be a future where we will not need in vivo? I am joined by Anjli Venkateswaran, Director of Strategic Partnerships for Charles River, to discuss this trending topic.

894 Listeners

1,924 Listeners

4,848 Listeners

418 Listeners

417 Listeners

6,351 Listeners

345 Listeners

24,239 Listeners

9,530 Listeners

112 Listeners

26,668 Listeners

492 Listeners

15 Listeners